Neli Mitkova Ermenlieva

Prof. Neli Mitkova Ermenlieva


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in Gels
Verified
Journal Article
Open access
PDF file
Nadezhda IvanovaNadezhda Ivanova
Nadezhda Ivanova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
LSLora Simeonova
Lora Simeonova
NVNeli Milenova Vilhelmova-Ilieva
Neli Milenova Vilhelmova-Ilieva
KBKameliya Bratoeva
Kameliya Bratoeva
Velichka AndonovaVelichka Andonova
Velichka Andonova
A combination of Poloxamer 407 (P407) and hydroxypropyl methylcellulose (HPMC) hydrosols is proposed as an in situ thermo-gelling vehicle for the nasal drug delivery of chlorhexidine–silver nanoparticles conjugates (SN-CX). Optimization of the formulation was carried out by applying varying ratios of P407 and HPMC in the presence and absence of SN-CX so that gelation would occur in the temperature range of the nasal cavity (30–34 °C). Mechanisms for the observed gelation phenomena were suggested based on viscosimetry, texture analysis, and dynamic light scattering. Tests were carried out for sprayability, washout time, in vitro drug release, ex vivo permeation, and antimicrobial activity. When applied separately, HPMC was found to lower the P407 gelation temperature (Tg), whereas SN-CX increased it. However, in the presence of HPMC, SN-CX interfered with the P407 micellar organization in a principally contrasting way while leading to an even further decrease in Tg. SN-CX-loaded nasal formulations composed of P407 16% and HPMC 0.1% demonstrated a desired gelation at 31.9 °C, good sprayability (52.95% coverage of the anterior nasal cavity), mucoadhesion for 70 min under simulated nasal clearance, expedient release and permeation, and preserved anti-infective activity against seasonal Influenza virus and beta-coronavirus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and other pathogens. Our findings suggest that the current development could be considered a potential formulation of a protective nasal spray against respiratory infections.

28 June 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
SASylvia Yordanova Atanasova-Stamova
Sylvia Yordanova Atanasova-Stamova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
GTGabriela Tsankova
Gabriela Tsankova
EGEmiliya Georgieva
Emiliya Georgieva
The increasing prevalence of antimicrobial resistance (AMR) demands novel strategies, including the use of plant-derived agents. This study investigates the chemical profile and in vitro antimicrobial activity of essential oil from Lavandula angustifolia (LEO), cultivated in Northeastern Bulgaria. Gas chromatography–mass spectrometry (GC-MS) analysis confirmed the presence of a linalool/linalyl acetate chemotype, characteristic of high-quality lavender oil. LEO demonstrated significant inhibitory activity against Escherichia coli ATCC 25922, with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 0.31% (v/v) and moderate to weak activity against other Gram-positive and fungal strains. Time–kill assays revealed a concentration-dependent bactericidal effect on E. coli. The addition of LEO at subinhibitory concentrations increased the inhibition zones for all antibiotics. In silico analysis identified functional protein clusters potentially modulated by LEO constituents, including targets related to membrane integrity and metabolic regulation. The findings indicate the potential of lavender essential oil as a natural antimicrobial adjuvant; however, additional in vivo and clinical investigations are necessary to validate its therapeutic use. Furthermore, molecular docking analysis revealed a high binding affinity of linalool and linalyl acetate towards the FabI protein of E.coli, suggesting a potential inhibitory mechanism at the molecular level.

9 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Nadezhda IvanovaNadezhda Ivanova
Nadezhda Ivanova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
LSLora Simeonova
Lora Simeonova
IKIliyan Nikolov Kolev
Iliyan Nikolov Kolev
ISIlia Zhelev Slavov
Ilia Zhelev Slavov
Velichka AndonovaVelichka Andonova
Velichka Andonova
This study explored the potential synergism within chlorhexidine–silver nanoparticle conjugates against Influenza type A, Staphylococcus aureus, Escherichia coli, and Candida albicans. Silver nanoparticles (SN) were obtained by the reduction of silver ions with green tea total phenolic extract and conjugated with chlorhexidine (Cx). The particles were characterized by UV-Vis and FTIR spectroscopies, dynamic light scattering, X-ray diffraction, and transmission electron microscopy. A stable negatively charged nano-silver colloid (ζ = −50.01) was obtained with an average hydrodynamic diameter of 92.34 nm. In the presence of chlorhexidine, the spectral data and the shift of the zeta potential to positive values (ζ = +44.59) revealed the successful sorption of the drug onto the silver surface. The conjugates (SN-Cx) demonstrated potentiation in their effects against S. aureus and C. albicans and synergism against E. coli with minimal inhibitory concentrations of SN at 5.5 µg/mL + Cx 8.8 µg/mL. The SN showed excellent virucidal properties, increasing with time, and demonstrated low toxicity. However, the coupling of the cationic chlorhexidine with nano-silver did not reduce its intrinsic cytotoxicity on various cell lines (MDCK, BJ, and A549). The newly synthesized antimicrobial agent exhibited an extended and promising therapeutic spectrum and needs to be further evaluated regarding the designated route of administration in three-dimensional cell models (e.g., nasal, bronchial, dermal, ocular, etc.).

7 April 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
SMSilvia Mihaylova
Silvia Mihaylova
ATAntoaneta Tsvetkova
Antoaneta Tsvetkova
SASylvia Yordanova Atanasova-Stamova
Sylvia Yordanova Atanasova-Stamova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
GTGabriela Tsankova
Gabriela Tsankova
YVYulian Voynikov
Yulian Voynikov
Antimicrobial resistance (AMR) poses a global health threat, with multidrug-resistant (MDR) Klebsiella pneumoniae and Pseudomonas aeruginosa contributing to the burden, especially in Bulgaria. This study investigates recent resistance trends of these pathogens in Bulgaria and evaluates the antibacterial effects of commercially available oregano (Origanum vulgare) and thyme (Thymus vulgaris) essential oils (EOs), both alone and in combination with conventional antibiotics. The chemical composition of the EOs was analyzed using gas chromatography–mass spectrometry (GC-MS), revealing carvacrol (84.2%) as the main component in oregano EO and thymol (45.74%) in thyme EO. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of the EOs were determined using the serial dilution method. Oregano EO exhibited lower MIC and MBC values (0.039–1.250%) compared to thyme EO (0.156–5.000%) against both pathogens. The disk diffusion assay showed that oregano EO exhibits more potent antibacterial effects than thyme EO in Klebsiella pneumoniae and Pseudomonas aeruginosa strains. The findings highlight the potential of EOs as adjunctive therapies to enhance the efficacy of conventional antibiotics against MDR Klebsiella pneumoniae and Pseudomonas aeruginosa strains in Bulgaria.

4 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YSYoana Sotirova
Yoana Sotirova
Nadezhda IvanovaNadezhda Ivanova
Nadezhda Ivanova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
NVNeli Milenova Vilhelmova-Ilieva
Neli Milenova Vilhelmova-Ilieva
LSLora Simeonova
Lora Simeonova
Velichka AndonovaVelichka Andonova
Velichka Andonova
Background/Objectives: This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich Hypericum perforatum L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms. Methods: Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 10031, and Candida albicans ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption. Results: The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against S. aureus (MBC 6.3 mg/mL), K. pneumoniae (MBC 97.7 µg/mL), and C. albicans (MFC < 48.8 µg/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against E. coli, P. aeruginosa, the HSV-1 extracellular virions, or viral adhesion. Conclusions: It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.

22 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
NINadezhda Ivanova
Nadezhda Ivanova
NENeli Mitkova Ermenlieva
Neli Mitkova Ermenlieva
LSLora Simeonova
Lora Simeonova
IKIliyan Nikolov Kolev
Iliyan Nikolov Kolev
ISIlia Zhelev Slavov
Ilia Zhelev Slavov
Velichka AndonovaVelichka Andonova
Velichka Andonova
This study explored the potential synergism within chlorhexidine-silver nanoparticles conjugates against Influenza type A, Staphylococcus aureus, Escherichia coli, and Candida albicans. Silver nanoparticles (SN) were obtained by the reduction of silver ions with green tea total phenolic extract and conjugated with chlorhexidine (Cx). The particles were characterized by UV-Vis and FTIR spectroscopies, dynamic light scattering, X-ray diffraction, and transmission electron microscopy. A stable negatively-charged nano-silver colloid (ζ=-50.01) was obtained with an average hydrodynamic diameter of 92.34 nm. In the presence of chlorhexidine, the spectral data and the shift of the zeta potential to positive values (ζ=+44.59) revealed the successful sorption of the drug onto the silver surface. The conjugates (SN-Cx) demonstrated potentiation in the effects against S. aureus and C. albicans, and synergism against E. coli with minimal inhibitory concentrations of SN 5.5 µg/mL+Cx 8.8 µg/mL. The SN showed excellent, increasing with time, virucidal properties, and low toxicity. The coupling of the cationic chlorhexidine with nano-silver, however, did not reduce its intrinsic cytotoxicity on various cell lines (MDCK, BJ, and А549). The newly-synthesized antimicrobial agent presented with an extended and promising therapeutic spectrum and needs to be further evaluated on relevant to the designated route of administration three-dimensional cell models (e.g., nasal, bronchial, dermal, ocular, etc.).